PITUITARY-ADRENAL RESPONSES TO CORTICOTROPIN-RELEASING HORMONE IN DIFFERENT DEGREES OF ADRENAL 21-HYDROXYLASE DEFICIENCY

被引:30
|
作者
MOREIRA, AC
ELIAS, LLK
机构
来源
关键词
D O I
10.1210/jc.74.1.198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
21-Hydroxylase congenital adrenal hyperplasia (21-OHCAH) involves a primary defect of the adrenal gland and a secondary involvement of ACTH secretion. The responses of the pituitary-adrenal axis to ovine CRH (oCRH, 1-mu-g/kg) were examined in subjects with different degrees of 21-OH deficiency. We studied 43 subjects: 7 classical and 6 nonclassical (NC) 21-OHCAH patients, 15 heterozygotes (HT) and 15 control subjects. Baseline plasma ACTH levels were higher in classical CAH than in NC-CAH, HT, and control subjects (mean +/- SEM, 66 +/- 14, 6 +/- 1.6, 4 +/- 0.5, and 5 +/- 0.5 pmol/L, respectively). The mean plasma ACTH response to oCRH in NC-CAH (17 +/- 3 pmol/L) was higher than in controls and HT (9 +/- 0.8 and 11 +/- 1.5 pmol/L). The highest ACTH responses to oCRH were obtained for classical CAH patients (126 +/- 29 pmol/L). Plasma cortisol rose after oCRH in control, HT, and NC-CAH patients but did not change in classical CAH. After oCRH, plasma 17-hydroxyprogesterone (17-OHP) were 4 +/- 0.5, 8 +/- 1.6, 93 +/- 28, and 359 +/- 110 nmol/L for controls, HT, NC-CAH, and classical patients, respectively. There was a significant correlation (r = 0.70) between 17-OHP and the ACTH responses to oCRH. The 17-OHP responses to oCRH were also correlated (r = 0.94) with the 17-OHP responses to the synthetic ACTH test. We conclude that the release of endogenous ACTH by oCRH result in graded 17-OHP responses on 21-OH deficiency. The present study also suggests that different degrees of adrenal biosynthetic defect may result in graded ACTH responses to oCRH.
引用
收藏
页码:198 / 203
页数:6
相关论文
共 50 条
  • [21] Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans
    Baram, TZ
    Mitchell, WG
    Halden, E
    MOLECULAR PSYCHIATRY, 1996, 1 (04) : 320 - 324
  • [22] BENZODIAZEPINES ATTENUATE THE PITUITARY-ADRENAL RESPONSES TO CORTICOTROPIN-RELEASING HORMONE IN HEALTHY-VOLUNTEERS, BUT NOT IN PATIENTS WITH CUSHINGS-SYNDROME
    KORBONITS, M
    TRAINER, PJ
    EDWARDS, R
    BESSER, GM
    GROSSMAN, AB
    CLINICAL ENDOCRINOLOGY, 1995, 43 (01) : 29 - 35
  • [23] EFFECT OF ORAL MORPHINE AND NALOXONE ON PITUITARY-ADRENAL RESPONSE IN MAN INDUCED BY HUMAN CORTICOTROPIN-RELEASING HORMONE
    ALLOLIO, B
    SCHULTE, HM
    DEUSS, U
    KALLABIS, D
    HAMEL, E
    WINKELMANN, W
    ACTA ENDOCRINOLOGICA, 1987, 114 (04): : 509 - 514
  • [24] REGULATION OF CORTICOTROPIN-RELEASING HORMONE RECEPTORS AND HYPOTHALAMIC PITUITARY-ADRENAL AXIS RESPONSIVENESS DURING COLD STRESS
    HAUGER, RL
    AGUILERA, G
    JOURNAL OF NEUROENDOCRINOLOGY, 1992, 4 (05) : 617 - 624
  • [25] CORTICOTROPIN-RELEASING FACTOR (CRF), A NEW AID IN THE DIAGNOSIS OF PITUITARY-ADRENAL DISORDERS
    HERMUS, ARMM
    PIETERS, GFFM
    PESMAN, GJ
    SMALS, AGH
    BENRAAD, TJ
    KLOPPENBORG, PWC
    NETHERLANDS JOURNAL OF MEDICINE, 1985, 28 (05): : 218 - 218
  • [26] PITUITARY-ADRENAL RESPONSIVENESS TO CORTICOTROPIN-RELEASING HORMONE IN PATIENTS RECEIVING CHRONIC, ALTERNATE DAY GLUCOCORTICOID THERAPY
    SCHURMEYER, TH
    TSOKOS, GC
    AVGERINOS, PC
    BALOW, JE
    DAGATA, R
    LORIAUX, DL
    CHROUSOS, GP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (01): : 22 - 27
  • [27] Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus
    Elias, LLK
    AntunesRodrigues, J
    Elias, PCL
    Moreira, AC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04): : 1243 - 1247
  • [28] THE RESPONSES OF THE PITUITARY-ADRENAL AXIS TO CORTICOTROPIN-RELEASING FACTOR (CRF) ARE UNAFFECTED BY ANGIOTENSIN-II BLOCKADE
    MORGANTI, A
    AMBROSI, B
    SALA, C
    CIANCI, L
    BOCHICCHIO, D
    TUROLO, L
    ZANCHETTI, A
    JOURNAL OF HYPERTENSION, 1986, 4 : S559 - S559
  • [29] EFFECTS OF PYRIDOSTIGMINE, CORTICOTROPIN-RELEASING HORMONE AND GROWTH HORMONE-RELEASING HORMONE ON THE PITUITARY-ADRENAL AXIS AND ON GROWTH-HORMONE SECRETION IN DEMENTIA
    MURIALDO, G
    FONZI, S
    TORRE, F
    COSTELLI, P
    SOLINAS, G
    TOSCA, P
    DIPAOLO, E
    PORRO, S
    ZERBI, F
    POLLERI, A
    NEUROPSYCHOBIOLOGY, 1993, 28 (04) : 177 - 183
  • [30] THE STRESS-RELEASING, BUT NOT CORTICOTROPIN-RELEASING HORMONE-INDUCED ACTIVATION OF THE PITUITARY-ADRENAL AXIS IN MAN IS BLOCKED BY ALPRAZOLAM
    ROHRER, T
    VONRICHTHOFEN, V
    SCHULZ, C
    BEYER, J
    LEHNERT, H
    HORMONE AND METABOLIC RESEARCH, 1994, 26 (04) : 200 - 206